Advised a biotechnology unicorn on an aborted acquisition valued at US$ 35 million
Collyer Law advised an American Biotechnology unicorn, specializing in gene therapy, on an aborted acquisition of a Singapore-Based...
Jan 15, 20241 min read
Advising Allozymes on commercial contracts
Collyer Law LLC advised Allozymes Pte. Ltd., a leading biotechnology company leveraging proprietary microfluidics technology for the...
Nov 1, 20231 min read
Advised Allozymes on commercial lease
Collyer Law advised Allozymes Pte Ltd, a leading deep technology company that applies its proprietary microfluidics technology to develop...
Jul 11, 20231 min read
Advising Docquity Holdings on US$44M Series C round
Collyer Law advised Docquity Holdings Pte. Ltd., a medical technology platform with Southeast Asia’s largest community of healthcare...
Sep 7, 20221 min read
Advising a Singapore-based healthcare startup on commercial agreements
Collyer Law advised Onward Health Research, a Singapore-based healthcare start-up. The Company enables hospitals and physicians in...
Oct 5, 20211 min read
